2022. Rho Kinase Inhibitors for Glaucoma and Optic Neuropathy Treatment: Enzyme Activity, Cell Effects, IOP-Lowering and Neuroprotection Perspectives. Open Access Journal of Ophthalmology. 7, 1 (Jan. 2022), 1–23. DOI:https://doi.org/10.23880/oajo-16000233.